• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RANGER; CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RANGER; CATHETER, PERCUTANEOUS Back to Search Results
Model Number 26102
Device Problems Deflation Problem (1149); Difficult to Remove (1528); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems No Code Available (3191); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/07/2020
Event Type  Injury  
Event Description
It was reported that failure to deflate and remove a balloon, and additional intervention occurred.An iliac angioplasty was performed on a common femoral artery (cfa).A 8.0 mm x 40mm, 80 cm ranger (dcb) balloon was advanced and inflated for three minutes to dilate the lesion.While attempting to deflate and remove the balloon through the sheath, the balloon would not fully deflate and could therefore not be removed through the sheath.It was noted that there were multiple attempts to deflate and inflate the balloon without success.The balloon was brought back as close as possible to the exit point of the cfa, where the balloon was then punctured with a percutaneous access needle, which facilitated the removal of the device through the sheath.The procedure was completed and no patient complications resulted in relation to this event.
 
Manufacturer Narrative
Device evaluated by mfr:the returned product consisted of a ranger (dcb) balloon catheter.The shaft, hypotube, tip and balloon were microscopically and visually examined.There was a pinhole at the distal marker band.There was no marker band damage detected.The inner shaft was separated 77.8cm from the strain relief.The outer shaft was stretched down starting 51.5cm from the strain relief and extending to the proximal end of the balloon.The balloon was prolapsed.Inspection of the remainder of the device presented no other damage or irregularities.
 
Event Description
It was reported that failure to deflate and removal difficulties occurred.An iliac angioplasty was performed on a common femoral artery (cfa).A 8.0 mm x 40mm, 80 cm ranger (dcb) balloon was advanced and inflated for three minutes to dilate the lesion.While attempting to deflate and remove the balloon through the sheath, the balloon would not fully deflate and could therefore not be removed through the sheath.It was noted that there were multiple attempts to deflate and inflate the balloon without success.The balloon was brought back as close as possible to the exit point of the cfa, where the balloon was then punctured with a percutaneous access needle, which facilitated the removal of the device through the sheath.The procedure was completed and no patient complications resulted in relation to this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RANGER
Type of Device
CATHETER, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key11119438
MDR Text Key225246546
Report Number2134265-2021-00015
Device Sequence Number1
Product Code DQY
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 03/22/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/23/2022
Device Model Number26102
Device Catalogue Number26102
Device Lot Number02413H20
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/18/2021
Initial Date Manufacturer Received 12/07/2020
Initial Date FDA Received01/05/2021
Supplement Dates Manufacturer Received03/18/2021
Supplement Dates FDA Received03/22/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-